Niclosamide a new chemotherapy agent? Pharmacokinetics of the potential anticancer drug in a patient cohort of the NIKOLO trial.

e14536Background: Patients with metastasized colorectal cancer (mCRC) progressing under standard therapy have poor prognosis and need further treatment alternatives. The S100 calcium binding protei...